SciVision Biotech Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 195.35 million compared to TWD 120.38 million a year ago. Net income was TWD 51.7 million compared to TWD 32.78 million a year ago.

Basic earnings per share from continuing operations was TWD 0.76 compared to TWD 0.5 a year ago. Diluted earnings per share from continuing operations was TWD 0.71 compared to TWD 0.47 a year ago.